Device_News

Partnerships

SpeeDx announced signing two new distribution partners, creating comprehensive access for customers to market-leading SpeeDx ResistancePlus® and PlexPCR® tests across Europe. AB ANALITICA will distribute throughout Italy and...

SpeeDx have signed of a further four distribution partners, in preparation to strengthen representation across Europe. Axonlab (Germany, Benelux and Switzerland), Vircell (Spain), Diamedica (Estonia, Latvia, and Lithuania) and Biomedica...

You may have never heard of it, but Mycoplasma genitalium - MG for short - is one of the most common sexually transmitted infections in Australia. Like chlamydia, MG can...

Cicada Innovations, a “super incubator”, and headquarters for the SpeeDx office, manufacturing and production facilities, have created an event to celebrate Australia’s progress in science-based innovation. The Nobel committee in...

Announcing the first publication for our ResistancePlus® MG assay, published in PLOS ONE in collaboration with Sepehr Tabrizi, PhD at the Royal Women’s Hospital in Melbourne, Australia. “The SpeeDx assay provides...

The establishment of a European subsidiary company, SpeeDx Limited, headquartered in the London Bioscience Innovation Centre, will support the future launch of SpeeDx PlexPCR® multiplex qPCR assays in the region. “We...